RECRUITING

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment. Aims are: Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental impact of the HIV/HCV intervention on HIV testing. Aim 2: To examine, using mixed-methods, the impact of the PC interventions on the initiation and sustained provision of HIV testing and timely linkage to care. Aim 3: To evaluate the health outcomes, health care utilization, and cost-effectiveness of the PC interventions compared incrementally to one another and to the control condition. Primary Hypothesis: 1. The two PC interventions will result in significantly higher proportions of patients tested for HIV than the information control condition during the "initial impact" period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Primary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary). 2. The HIV/HCV PC intervention will result in significantly higher proportions of patients tested for HIV than the HIV PC intervention during the initial impact period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Secondary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary).

Official Title

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs

Quick Facts

Study Start:2017-06-12
Study Completion:2026-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03135886

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Eligible sites must:
  2. 1. See at least 150 unduplicated patients/year/site
  3. 2. Be capable and willing to prospectively collect data on the number of patients who a) are offered any HIV and/or HCV tests; b) completed these tests; c) are referred to care/evaluation (and type of referral) if positive; and d) are linked to care/evaluation within 30 days of diagnosis
  4. 3. Be capable and willing to provide patient demographics, testing data within demographic categories of gender and race/ethnicity (in aggregate) and data on HIV/HCV test reimbursement processes and outcomes
  5. 4. Have key staff willing to consent to participate in study surveys, qualitative interviews and intervention coaching throughout the study
  1. * Sites will be excluded if:
  2. 1. Over 50% of patients served in the prior 6 months were HIV or HCV tested
  3. 2. They are terminated via PI decision/discretion

Contacts and Locations

Study Contact

Lauren Gooden, PhD
CONTACT
786-703-9819
lkg2129@columbia.edu
Terri Liguori, M.Ed., Ed.S.
CONTACT
786-510-3666
tl2547@columbia.edu

Principal Investigator

Lisa Metsch, PhD
PRINCIPAL_INVESTIGATOR
Columbia University
Daniel Feaster, PhD
PRINCIPAL_INVESTIGATOR
University of Miami
Jemima Frimpong, PhD
PRINCIPAL_INVESTIGATOR
New York University Abu Dhabi
Lauren Gooden, PhD
STUDY_DIRECTOR
Columbia University

Study Locations (Sites)

Columbia University Medical Center
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Lisa Metsch, PhD, PRINCIPAL_INVESTIGATOR, Columbia University
  • Daniel Feaster, PhD, PRINCIPAL_INVESTIGATOR, University of Miami
  • Jemima Frimpong, PhD, PRINCIPAL_INVESTIGATOR, New York University Abu Dhabi
  • Lauren Gooden, PhD, STUDY_DIRECTOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-06-12
Study Completion Date2026-01-31

Study Record Updates

Study Start Date2017-06-12
Study Completion Date2026-01-31

Terms related to this study

Keywords Provided by Researchers

  • HIV
  • HIV Testing
  • Hepatitis C Virus Testing
  • Opioid Use Disorder Treatment
  • Substance Use Disorders Treatment
  • Hepatitis C Virus
  • Practice Coaching

Additional Relevant MeSH Terms

  • HIV/AIDS
  • Hepatitis C
  • Substance Use Disorders
  • Opioid-use Disorder